Mr
Jason
Lessard

Partner & Patent Attorney

Birmingham Office London Office Rennes Office

Engineering

Telephone. +44(0) 121 265 7930
Mobile. +44(0) 791 400 9820
Email. [email protected]

Experience

Jason is an intellectual property professional who focuses on helping clients develop and extract value from their IP portfolios.

Jason has a unique mix of skills and experience, from running an $8 million sales portfolio before entering the patent profession to developing a successful private practice and from successfully completing the USPTO Patent Bar exam to qualifying as a pilot (EASA Part-FCL IMC/IRR).

Jason is a bilingual (French and English) European and Chartered UK Patent Attorney and has Limited Recognition before the US Patent and Trade Mark Office. He was a European Trade Mark and Design Attorney before the UK left the EU.

The majority of Jason's work is in advising SMEs and multinationals on their IP strategy, drafting, filing and prosecuting patent and design applications throughout the world and conducting freedom-to-operate projects.

His knowledge of both European and US patent systems, together with his commercial and sales experience gives Jason a unique advantage when advising both US and European clients.

Qualifications

Patent Attorney

Chartered (UK)
European
USA (Limited Recognition)


BSC

BASc (Mech Eng), Hons

Related News

Event - 21st-22nd September 2022

Medical Technology Ireland 2022

Medical Technology Ireland Conference 2022 will be held on 21-22 September at the Galway Racecource. Medical Technology Ireland is a new high-profile National and International event attracting global suppliers to …

Event details

Artificial intelligence inventions in healthcare – can you patent them in Europe?

Artificial Intelligence (AI) has moved from the realm of science fiction firmly into the mainstream of technological innovation. Trained AI models in some cases are able to perform data analysis …

Read article

Patenting digital mental health

Mental health and behavioural disorders have a profound impact on wellbeing worldwide, with an estimated 13% of the global population suffering from a mental health or substance use disorder [1]. …

Read article

Patenting antibodies in the US and Europe

Is the USPTO now stricter than the EPO on antibody claims? A consideration of recent developments from both sides of the pond. Patent protection for monoclonal antibodies, bispecific antibodies and …

Read article

Patentability of Simulations in Europe

Simulations offer a powerful tool in modern-day engineering. Subjecting designs to initial testing in a simulated environment will, for many designs, reduce costs owing to reduced needs to produce and …

Read article

Blockbuster blood thinning patent revoked

Summary Mr Justice Meade has revoked Bristol Myers Squibb’s (BMS) European patent No. EP1427415 (EP’415) and corresponding supplementary protection certificate (SPC) that relate to the compound Apixaban (ELIQUIS) for lack …

Read article
Event - 10th May 2022

The HGF IP in Healthcare Conference 2022

After a challenging couple of years, we are delighted to invite you to join us for HGF’s eighth annual IP in Healthcare Conference. We will review the latest intellectual property …

Event details
Event - 10th May 2022

HGF UPC events in Germany and Austria 2022

HGF is holding a webinar and an in-person event covering the UPC in Germany and Austria this Spring. The provisional phase of the Unified Patent Court (UPC) is now underway …

Event details

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.